Family and principal investment groups participated in venture director deals totalling $68.1 billion in 2025, with life science investments accounting for $12.5 billion, according to FamCap Analytics.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in